Literature DB >> 29360419

Multiple Organ Dysfunction: The Defining Syndrome of Sepsis.

Markus T Ziesmann1, John C Marshall1.   

Abstract

BACKGROUND: Sepsis as a process has been recognized since the time of the Ancient Greeks. The concept has evolved recently to reflect a disease process of a severe, systemic response to infection. Acute, life-threatening but potentially reversible organ dysfunction is its hallmark, and unresolving organ dysfunction is the dominant cause of death in critical illness. Its evolution, persistence, and resolution reflect a complex interplay of factors originating in the initial inciting insult, the innate immune and metabolic response of the host, and the beneficial and harmful consequences of intensive care unit (ICU) supportive care. DISCUSSION: We describe the common clinical manifestations of the six prototypic organ system dysfunction syndromes of severe sepsis and review the associated epidemiology and suspected pathophysiology.

Entities:  

Keywords:  acute respiratory distress syndrome; intensive care; multiple organ dysfunction syndrome; sepsis

Mesh:

Year:  2018        PMID: 29360419     DOI: 10.1089/sur.2017.298

Source DB:  PubMed          Journal:  Surg Infect (Larchmt)        ISSN: 1096-2964            Impact factor:   2.150


  17 in total

1.  Multiple organ dysfunction - we must take a closer look at muscle wasting!

Authors:  Cassiano Teixeira; Felippe Leopoldo Dexheimer Neto; Régis Goulart Rosa
Journal:  Rev Bras Ter Intensiva       Date:  2019-05-13

2.  Multiple Organ Dysfunction Syndrome Caused by Sepsis: Risk Factor Analysis.

Authors:  Guo-Dong Sun; Yang Zhang; Shan-Shan Mo; Ming-Yan Zhao
Journal:  Int J Gen Med       Date:  2021-10-27

3.  Relationship between amikacin pharmacokinetics and biological parameters associated with organ dysfunction: a case series study of critically ill patients with intra-abdominal sepsis.

Authors:  Bita Shahrami; Aida Sefidani Forough; Seyedeh Sana Khezrnia; Farhad Najmeddin; Amir Ahmad Arabzadeh; Mohammad Reza Rouini; Atabak Najafi; Mojtaba Mojtahedzadeh
Journal:  Eur J Hosp Pharm       Date:  2021-11-11

Review 4.  The NLRP3 Inflammasome and Its Role in Sepsis Development.

Authors:  Lucinéia Gainski Danielski; Amanda Della Giustina; Sandra Bonfante; Tatiana Barichello; Fabricia Petronilho
Journal:  Inflammation       Date:  2020-02       Impact factor: 4.092

5.  Low-power infrared laser modulates telomere length in heart tissue from an experimental model of acute lung injury.

Authors:  Larissa Alexsandra da Silva Neto Trajano; Luiz Philippe da Silva Sergio; Diego Sá Leal de Oliveira; Eduardo Tavares Lima Trajano; Marco Aurélio Dos Santos Silva; Flavia de Paoli; André Luiz Mencalha; Adenilson de Souza da Fonseca
Journal:  Photochem Photobiol Sci       Date:  2021-05-19       Impact factor: 3.982

6.  Predicting the requirement for renal replacement therapy in intensive care patients with sepsis.

Authors:  Axel Nierhaus; Frank Bloos; Darius Cameron Wilson; Gunnar Elke; Patrick Meybohm
Journal:  Crit Care       Date:  2018-08-20       Impact factor: 9.097

7.  CD63 and C3AR1: The Potential Molecular Targets in the Progression of Septic Shock.

Authors:  Ning Yu; Xuefang Liu; Dandan Shi; Long Bai; Tianfu Niu; Ya Liu
Journal:  Int J Gen Med       Date:  2022-01-19

8.  Contributory Role of BLT2 in the Production of Proinflammatory Cytokines in Cecal Ligation and Puncture-Induced Sepsis.

Authors:  Donghwan Park; MyungJa Ro; A-Jin Lee; Dong-Wook Kwak; Yunro Chung; Jae-Hong Kim
Journal:  Mol Cells       Date:  2021-12-31       Impact factor: 5.034

Review 9.  Organ crosstalk: the potent roles of inflammation and fibrotic changes in the course of organ interactions.

Authors:  Ferah Armutcu
Journal:  Inflamm Res       Date:  2019-07-20       Impact factor: 4.575

10.  Organ failure, aetiology and 7-day all-cause mortality among acute adult patients on arrival to an emergency department: a hospital-based cohort study.

Authors:  Peter Bank Pedersen; Daniel Pilsgaard Henriksen; Mikkel Brabrand; Annmarie Touborg Lassen
Journal:  Eur J Emerg Med       Date:  2021-12-01       Impact factor: 4.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.